INVO Bioscience Inc INVO
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if INVO is a good fit for your portfolio.
News
Trading Information
- Previous Close Price
- $1.37
- Day Range
- $1.18–1.37
- 52-Week Range
- $0.50–10.50
- Bid/Ask
- $1.18 / $1.22
- Market Cap
- $3.40 Mil
- Volume/Avg
- 917,858 / 4.3 Mil
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 0.69
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
INVO Bioscience Inc operates as a medical device company focused on the Assisted Reproductive Technology (ART) marketplace that is creating simplified, lower-cost treatments for patients diagnosed with infertility. The company has developed the INVOcell device and procedure, the first Intravaginal Culture (IVC) system granted FDA clearance in the United States used for the incubation of eggs and sperm during fertilization and early embryo development. The company sells its products to physicians directly; and IVF centers, medical practices, and physicians through distributors.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Value
- Total Number of Employees
- 16
- Website
- https://www.invobio.com
Valuation
|
Metric
|
INVO
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | 0.69 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
INVO
|
|---|---|
Quick Ratio | 0.05 |
Current Ratio | 0.15 |
Interest Coverage | −7.65 |
Quick Ratio
INVO
Profitability
|
Metric
|
INVO
|
|---|---|
Return on Assets (Normalized) | −58.80% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | −111.55% |
Return on Assets
INVO
Medical Devices Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ABT
| Abbott Laboratories | Ndfxtgcn | Yhnyh | $185.8 Bil | |
SYK
| Stryker Corp | Ypvpgkwvc | Xszt | $124.7 Bil | |
MDT
| Medtronic PLC | Rxchxnfh | Nfmppnt | $105.2 Bil | |
BSX
| Boston Scientific Corp | Yncnnhrqn | Vrtspc | $99.0 Bil | |
EW
| Edwards Lifesciences Corp | Pfzvkdbxt | Gttfnt | $52.3 Bil | |
DXCM
| DexCom Inc | Ysbrxnqgh | Qmvfj | $52.1 Bil | |
ZBH
| Zimmer Biomet Holdings Inc | Vjkqvcbhvg | Jjsj | $24.8 Bil | |
ALGN
| Align Technology Inc | Gflctpdh | Sykntv | $22.6 Bil | |
PHG
| Koninklijke Philips NV ADR | Znvcjrgty | Jfxdxx | $18.5 Bil | |
PODD
| Insulet Corp | Tmszcqbh | Fqnpf | $11.5 Bil |